ENTRY       mmu04928                    Pathway
NAME        Parathyroid hormone synthesis, secretion and action - Mus musculus (mouse)
DESCRIPTION Parathyroid hormone (PTH) is a key regulator of calcium and phosphorus homeostasis. The principal regulators of PTH secretion are extracellular ionized calcium (Ca2+) and 1,25-dihydroxyvitamin D (1,25(OH)2D3). Under conditions of dietary Ca restriction, a decrement in serum Ca concentration induces release of PTH from the parathyroid gland. PTH acts on bone and kidney to stimulate bone turnover, increase the circulating levels of 1,25(OH)2D3 and calcium and inhibit the reabsorption of phosphate from the glomerular filtrate. This hormone exerts its actions via binding to the PTH/PTH-related peptide receptor (PTH1R). PTH1R primarily activates two sub-types of heterotrimeric Gproteins: Gs and Gq , which in turn regulate the activity of adenylyl cyclases and phospholipase C (PLC) that control the flow of cAMP/PKA and IP/PKC signaling cascades, respectively.
CLASS       Organismal Systems; Endocrine system
PATHWAY_MAP mmu04928  Parathyroid hormone synthesis, secretion and action
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        12374  Casr; calcium-sensing receptor [KO:K04612]
            14677  Gnai1; guanine nucleotide binding protein (G protein), alpha inhibiting 1 [KO:K04630]
            14679  Gnai3; guanine nucleotide binding protein (G protein), alpha inhibiting 3 [KO:K04630]
            14678  Gnai2; guanine nucleotide binding protein (G protein), alpha inhibiting 2 [KO:K04630]
            432530  Adcy1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
            210044  Adcy2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]
            104111  Adcy3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
            104110  Adcy4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
            224129  Adcy5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
            11512  Adcy6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
            11513  Adcy7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
            11514  Adcy8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
            11515  Adcy9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
            14682  Gnaq; guanine nucleotide binding protein, alpha q polypeptide [KO:K04634]
            14672  Gna11; guanine nucleotide binding protein, alpha 11 [KO:K04635]
            18795  Plcb1; phospholipase C, beta 1 [KO:K05858] [EC:3.1.4.11]
            18797  Plcb3; phospholipase C, beta 3 [KO:K05858] [EC:3.1.4.11]
            18798  Plcb4; phospholipase C, beta 4 [KO:K05858] [EC:3.1.4.11]
            18796  Plcb2; phospholipase C, beta 2 [KO:K05858] [EC:3.1.4.11]
            16438  Itpr1; inositol 1,4,5-trisphosphate receptor 1 [KO:K04958]
            16439  Itpr2; inositol 1,4,5-triphosphate receptor 2 [KO:K04959]
            16440  Itpr3; inositol 1,4,5-triphosphate receptor 3 [KO:K04960]
            14531  Gcm1; glial cells missing homolog 1 [KO:K21598]
            107889  Gcm2; glial cells missing homolog 2 [KO:K21598]
            16658  Mafb; v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) [KO:K09036]
            14462  Gata3; GATA binding protein 3 [KO:K17895]
            20683  Sp1; trans-acting transcription factor 1 [KO:K04684]
            22337  Vdr; vitamin D (1,25-dihydroxyvitamin D3) receptor [KO:K08539]
            20181  Rxra; retinoid X receptor alpha [KO:K08524]
            20182  Rxrb; retinoid X receptor beta [KO:K08525]
            20183  Rxrg; retinoid X receptor gamma [KO:K08526]
            64654  Fgf23; fibroblast growth factor 23 [KO:K22428]
            14182  Fgfr1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
            16591  Kl; klotho [KO:K14756] [EC:3.2.1.31]
            26413  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            26417  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            13653  Egr1; early growth response 1 [KO:K09203]
            19226  Pth; parathyroid hormone [KO:K05261]
            19227  Pthlh; parathyroid hormone-like peptide [KO:K22608]
            19228  Pth1r; parathyroid hormone 1 receptor [KO:K04585]
            109689  Arrb1; arrestin, beta 1 [KO:K04439]
            216869  Arrb2; arrestin, beta 2 [KO:K04439]
            11836  Araf; Araf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
            109880  Braf; Braf transforming gene [KO:K04365] [EC:2.7.11.1]
            110157  Raf1; v-raf-leukemia viral oncogene 1 [KO:K04366] [EC:2.7.11.1]
            26395  Map2k1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            18750  Prkca; protein kinase C, alpha [KO:K02677] [EC:2.7.11.13]
            18751  Prkcb; protein kinase C, beta [KO:K19662] [EC:2.7.11.13]
            18752  Prkcg; protein kinase C, gamma [KO:K19663] [EC:2.7.11.13]
            194352  Trpv5; transient receptor potential cation channel, subfamily V, member 5 [KO:K04974]
            20505  Slc34a1; solute carrier family 34 (sodium phosphate), member 1 [KO:K14683]
            20531  Slc34a2; solute carrier family 34 (sodium phosphate), member 2 [KO:K14683]
            142681  Slc34a3; solute carrier family 34 (sodium phosphate), member 3 [KO:K14683]
            26941  Slc9a3r1; solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 [KO:K13365]
            14683  Gnas; GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus [KO:K04632]
            18577  Pde4a; phosphodiesterase 4A, cAMP specific [KO:K13293] [EC:3.1.4.53]
            18578  Pde4b; phosphodiesterase 4B, cAMP specific [KO:K13293] [EC:3.1.4.53]
            110385  Pde4c; phosphodiesterase 4C, cAMP specific [KO:K13293] [EC:3.1.4.53]
            238871  Pde4d; phosphodiesterase 4D, cAMP specific [KO:K13293] [EC:3.1.4.53]
            18747  Prkaca; protein kinase, cAMP dependent, catalytic, alpha [KO:K04345] [EC:2.7.11.11]
            18749  Prkacb; protein kinase, cAMP dependent, catalytic, beta [KO:K04345] [EC:2.7.11.11]
            13115  Cyp27b1; cytochrome P450, family 27, subfamily b, polypeptide 1 [KO:K07438] [EC:1.14.15.18]
            13081  Cyp24a1; cytochrome P450, family 24, subfamily a, polypeptide 1 [KO:K07436] [EC:1.14.15.16]
            17258  Mef2a; myocyte enhancer factor 2A [KO:K09260]
            17260  Mef2c; myocyte enhancer factor 2C [KO:K04454]
            17261  Mef2d; myocyte enhancer factor 2D [KO:K09262]
            74499  Sost; sclerostin [KO:K16834]
            18227  Nr4a2; nuclear receptor subfamily 4, group A, member 2 [KO:K08558]
            17938  Naca; nascent polypeptide-associated complex alpha polypeptide [KO:K03626]
            16478  Jund; jun D proto-oncogene [KO:K04449]
            12097  Bglap2; bone gamma-carboxyglutamate protein 2 [KO:K22609]
            12095  Bglap3; bone gamma-carboxyglutamate protein 3 [KO:K22609]
            12096  Bglap; bone gamma carboxyglutamate protein [KO:K22609]
            16973  Lrp5; low density lipoprotein receptor-related protein 5 [KO:K03068]
            16974  Lrp6; low density lipoprotein receptor-related protein 6 [KO:K03068]
            12912  Creb1; cAMP responsive element binding protein 1 [KO:K05870]
            11909  Atf2; activating transcription factor 2 [KO:K04450]
            12913  Creb3; cAMP responsive element binding protein 3 [KO:K09048]
            26427  Creb3l1; cAMP responsive element binding protein 3-like 1 [KO:K09048]
            208647  Creb3l2; cAMP responsive element binding protein 3-like 2 [KO:K09048]
            208677  Creb3l3; cAMP responsive element binding protein 3-like 3 [KO:K09048]
            78284  Creb3l4; cAMP responsive element binding protein 3-like 4 [KO:K09048]
            11911  Atf4; activating transcription factor 4 [KO:K04374]
            231991  Creb5; cAMP responsive element binding protein 5 [KO:K09047]
            12915  Atf6b; activating transcription factor 6 beta [KO:K09049]
            21943  Tnfsf11; tumor necrosis factor (ligand) superfamily, member 11 [KO:K05473]
            12043  Bcl2; B cell leukemia/lymphoma 2 [KO:K02161]
            12575  Cdkn1a; cyclin-dependent kinase inhibitor 1A (P21) [KO:K06625]
            14281  Fos; FBJ osteosarcoma oncogene [KO:K04379]
            12393  Runx2; runt related transcription factor 2 [KO:K09278]
            17386  Mmp13; matrix metallopeptidase 13 [KO:K07994] [EC:3.4.24.-]
            14673  Gna12; guanine nucleotide binding protein, alpha 12 [KO:K04346]
            14674  Gna13; guanine nucleotide binding protein, alpha 13 [KO:K04639]
            16801  Arhgef1; Rho guanine nucleotide exchange factor (GEF) 1 [KO:K12330]
            213498  Arhgef11; Rho guanine nucleotide exchange factor (GEF) 11 [KO:K12331]
            75547  Akap13; A kinase (PRKA) anchor protein 13 [KO:K16529]
            11848  Rhoa; ras homolog family member A [KO:K04513]
            67653  4930544G11Rik; RIKEN cDNA 4930544G11 gene [KO:K04513]
            18806  Pld2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
            18805  Pld1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
            17387  Mmp14; matrix metallopeptidase 14 (membrane-inserted) [KO:K07763] [EC:3.4.24.80]
            17388  Mmp15; matrix metallopeptidase 15 [KO:K07995] [EC:3.4.24.-]
            17389  Mmp16; matrix metallopeptidase 16 [KO:K07996] [EC:3.4.24.-]
            23948  Mmp17; matrix metallopeptidase 17 [KO:K07997] [EC:3.4.24.-]
            17391  Mmp24; matrix metallopeptidase 24 [KO:K08002] [EC:3.4.24.-]
            240047  Mmp25; matrix metallopeptidase 25 [KO:K08003] [EC:3.4.24.-]
            15200  Hbegf; heparin-binding EGF-like growth factor [KO:K08523]
            13649  Egfr; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
COMPOUND    C00009  Orthophosphate
            C00020  AMP
            C00076  Calcium cation
            C00165  Diacylglycerol
            C00575  3',5'-Cyclic AMP
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01330  Sodium cation
            C01561  Calcidiol
            C01673  Calcitriol
            C18231  Calcitetrol
REFERENCE   PMID:27065162
  AUTHORS   Khundmiri SJ, Murray RD, Lederer E
  TITLE     PTH and Vitamin D.
  JOURNAL   Compr Physiol 6:561-601 (2016)
            DOI:10.1002/cphy.c140071
REFERENCE   PMID:28363951
  AUTHORS   Bastepe M, Turan S, He Q
  TITLE     Heterotrimeric G proteins in the control of parathyroid hormone actions.
  JOURNAL   J Mol Endocrinol 58:R203-R224 (2017)
            DOI:10.1530/JME-16-0221
REFERENCE   PMID:20703892
  AUTHORS   Vilardaga JP, Romero G, Friedman PA, Gardella TJ
  TITLE     Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.
  JOURNAL   Cell Mol Life Sci 68:1-13 (2011)
            DOI:10.1007/s00018-010-0465-9
REFERENCE   PMID:29291826
  AUTHORS   Naveh-Many T, Silver J
  TITLE     Transcription factors that determine parathyroid development power PTH expression.
  JOURNAL   Kidney Int 93:7-9 (2018)
            DOI:10.1016/j.kint.2017.08.026
REFERENCE   PMID:25917456
  AUTHORS   Han SI, Tsunekage Y, Kataoka K
  TITLE     Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1.
  JOURNAL   Mol Cell Endocrinol 411:113-20 (2015)
            DOI:10.1016/j.mce.2015.04.018
REFERENCE   PMID:22622503
  AUTHORS   Ferre S, Hoenderop JG, Bindels RJ
  TITLE     Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis.
  JOURNAL   Kidney Int 82:1157-66 (2012)
            DOI:10.1038/ki.2012.179
REFERENCE   PMID:20010546
  AUTHORS   Komaba H, Fukagawa M
  TITLE     FGF23-parathyroid interaction: implications in chronic kidney disease.
  JOURNAL   Kidney Int 77:292-8 (2010)
            DOI:10.1038/ki.2009.466
REFERENCE   PMID:27194212
  AUTHORS   Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F
  TITLE     Primary hyperparathyroidism.
  JOURNAL   Nat Rev Dis Primers 2:16033 (2016)
            DOI:10.1038/nrdp.2016.33
REFERENCE   PMID:21576356
  AUTHORS   de Groot T, Kovalevskaya NV, Verkaart S, Schilderink N, Felici M, van der Hagen EA, Bindels RJ, Vuister GW, Hoenderop JG
  TITLE     Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone.
  JOURNAL   Mol Cell Biol 31:2845-53 (2011)
            DOI:10.1128/MCB.01319-10
REFERENCE   PMID:17975663
  AUTHORS   Hernando N, Wagner C, Biber J, Murer H
  TITLE     Kidney kinase network regulates renal ion cotransport.
  JOURNAL   J Clin Invest 117:3179-82 (2007)
            DOI:10.1172/JCI33859
REFERENCE   PMID:22628548
  AUTHORS   Wang B, Means CK, Yang Y, Mamonova T, Bisello A, Altschuler DL, Scott JD, Friedman PA
  TITLE     Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport.
  JOURNAL   J Biol Chem 287:24148-63 (2012)
            DOI:10.1074/jbc.M112.369405
REFERENCE   PMID:21097685
  AUTHORS   Crenshaw TD, Rortvedt LA, Hassen Z
  TITLE     Triennial Growth Symposium: a novel pathway for vitamin D-mediated phosphate homeostasis: implications for skeleton growth and mineralization.
  JOURNAL   J Anim Sci 89:1957-64 (2011)
            DOI:10.2527/jas.2010-3411
REFERENCE   PMID:11698670
  AUTHORS   Zierold C, Mings JA, DeLuca HF
  TITLE     Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.
  JOURNAL   Proc Natl Acad Sci U S A 98:13572-6 (2001)
            DOI:10.1073/pnas.241516798
REFERENCE   PMID:20074973
  AUTHORS   Kramer I, Keller H, Leupin O, Kneissel M
  TITLE     Does osteocytic SOST suppression mediate PTH bone anabolism?
  JOURNAL   Trends Endocrinol Metab 21:237-44 (2010)
            DOI:10.1016/j.tem.2009.12.002
REFERENCE   PMID:17696759
  AUTHORS   Leupin O, Kramer I, Collette NM, Loots GG, Natt F, Kneissel M, Keller H
  TITLE     Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
  JOURNAL   J Bone Miner Res 22:1957-67 (2007)
            DOI:10.1359/jbmr.070804
REFERENCE   PMID:24940803
  AUTHORS   Meir T, Durlacher K, Pan Z, Amir G, Richards WG, Silver J, Naveh-Many T
  TITLE     Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.
  JOURNAL   Kidney Int 86:1106-15 (2014)
            DOI:10.1038/ki.2014.215
REFERENCE   PMID:29413898
  AUTHORS   Pellicelli M, Hariri H, Miller JA, St-Arnaud R
  TITLE     Lrp6 is a target of the PTH-activated alphaNAC transcriptional coregulator.
  JOURNAL   Biochim Biophys Acta 1861:61-71 (2018)
            DOI:10.1016/j.bbagrm.2018.01.008
REFERENCE   PMID:12364326
  AUTHORS   Fu Q, Jilka RL, Manolagas SC, O'Brien CA
  TITLE     Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.
  JOURNAL   J Biol Chem 277:48868-75 (2002)
            DOI:10.1074/jbc.M208494200
REFERENCE   PMID:19716455
  AUTHORS   O'Brien CA
  TITLE     Control of RANKL gene expression.
  JOURNAL   Bone 46:911-9 (2010)
            DOI:10.1016/j.bone.2009.08.050
REFERENCE   PMID:17517365
  AUTHORS   Jilka RL
  TITLE     Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.
  JOURNAL   Bone 40:1434-46 (2007)
            DOI:10.1016/j.bone.2007.03.017
REFERENCE   PMID:8810350
  AUTHORS   Pearman AT, Chou WY, Bergman KD, Pulumati MR, Partridge NC
  TITLE     Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE.
  JOURNAL   J Biol Chem 271:25715-21 (1996)
            DOI:10.1074/jbc.271.41.25715
REFERENCE   PMID:16164977
  AUTHORS   Boumah CE, Selvamurugan N, Partridge NC
  TITLE     Transcription in the osteoblast: regulatory mechanisms utilized by parathyroid hormone and transforming growth factor-beta.
  JOURNAL   Prog Nucleic Acid Res Mol Biol 80:287-321 (2005)
            DOI:10.1016/S0079-6603(05)80007-8
REFERENCE   PMID:11274169
  AUTHORS   Hess J, Porte D, Munz C, Angel P
  TITLE     AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1  composite element.
  JOURNAL   J Biol Chem 276:20029-38 (2001)
            DOI:10.1074/jbc.M010601200
REFERENCE   PMID:15705779
  AUTHORS   Singh AT, Gilchrist A, Voyno-Yasenetskaya T, Radeff-Huang JM, Stern PH
  TITLE     G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells.
  JOURNAL   Endocrinology 146:2171-5 (2005)
            DOI:10.1210/en.2004-1283
REFERENCE   PMID:12738761
  AUTHORS   Ahmed I, Gesty-Palmer D, Drezner MK, Luttrell LM
  TITLE     Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.
  JOURNAL   Mol Endocrinol 17:1607-21 (2003)
            DOI:10.1210/me.2002-0040
REFERENCE   PMID:17107942
  AUTHORS   Sneddon WB, Yang Y, Ba J, Harinstein LM, Friedman PA
  TITLE     Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.
  JOURNAL   Am J Physiol Renal Physiol 292:F1028-34 (2007)
            DOI:10.1152/ajprenal.00288.2006
REL_PATHWAY mmu04012  ErbB signaling pathway
            mmu04020  Calcium signaling pathway
            mmu04024  cAMP signaling pathway
            mmu04310  Wnt signaling pathway
            mmu04380  Osteoclast differentiation
            mmu04961  Endocrine and other factor-regulated calcium reabsorption
KO_PATHWAY  ko04928
///
